Rubius Therapeutics, Inc., a prominent biopharmaceutical venture, is devoted to pioneering cutting-edge red cell therapeutics as a means of treating cancer and autoimmune diseases. The firm was once known by the moniker VL26, Inc.; yet, in 2015, underwent a rebranding initiative and adopted its present-day name. Rubius Therapeutics was established in 2013 and is headquartered in Foxborough, Massachusetts.
Rubius Therapeutics's ticker is RUBY
The company's shares trade on the NASDAQ stock exchange
They are based in Cambridge, Massachusetts
There are 51-200 employees working at Rubius Therapeutics
It is https://www.rubiustx.com/
Rubius Therapeutics is in the Healthcare sector
Rubius Therapeutics is in the Biotechnology industry
The following five companies are Rubius Therapeutics's industry peers:
- Plains All American Pipeline